Search | Page 4 | Aplastic Anemia and MDS International Foundation


Search results

  1. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    ... with standard non-transplant therapy, who will receive a peripheral blood stem cell transplant . A malignant disease includes the following: ...

    Clinical Trial last updated 05/03/2016 - 10:47am.

  2. HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies

    ... of using a system called CliniMACS to remove Tcells from blood stem cells . Removing T-cells may help stop a side effect called ...

    Clinical Trial last updated 04/29/2016 - 3:18pm.

  3. MEDALIST Trial

    ... (MDS) with ring sideroblasts (≥ 15%) who require Red blood cell (RBC) transfusions. ... is present. - < 5% blasts in bone marrow - Peripheral blood WBC count < 13,000/μL Requires RBC transfusions, as ...

    Clinical Trial last updated 02/22/2017 - 11:42am.

  4. A Phase 1, Multicenter, Open-Label, Dose-Escalation and Expansion, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-120 in Subjects with Advanced Hematologic Malignancies with an IDH1 Mutation

    ... must be amenable to serial bone marrow biopsies, peripheral blood sampling, and urine sampling during the study. Subjects must have ...

    Clinical Trial last updated 02/22/2017 - 11:21am.

  5. Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

    ... recover faster following a stem cell transplant . Blood stem cells are very young blood cells that grow in the body to ... hemoglobin ) Patients have a plan to receive a peripheral blood stem cell collection. Patients must have no change in ...

    Clinical Trial last updated 04/29/2016 - 1:11pm.

  6. Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoing Donor Peripheral Blood Stem Cell Transplant

    ... in patients with hematologic malignancies undergoing donor peripheral blood stem cell (PBSC) transplant. Giving chemotherapy and total-body ...

    Clinical Trial last updated 04/28/2016 - 12:07pm.

  7. Transplantation


    Page last updated 01/20/2015 - 4:45pm.

  8. Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... Patients undergo cluster of differentiation (CD)34+ peripheral blood stem cell transplant on day 0. GVHD PROPHYLAXIS: Patients receive ...

    Clinical Trial last updated 04/27/2016 - 1:37pm.

  9. Reduced Intensity Conditioning in Patients Aged ≤35 With Non-Malignant Disorders Undergoing UCBT, BMT, or PBSCT (RIC HSCT NMD)

    ... donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders ...

    Clinical Trial last updated 06/13/2016 - 2:18pm.

  10. REVERSE 1 INCB 18424-271

    ... (allo-HSCT) from any donor source using bone marrow , peripheral blood stem cells , or cord blood for hematologic malignancies. ...

    Clinical Trial last updated 12/14/2016 - 11:24am.